The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A groundbreaking study reveals that ultrasensitive ctDNA assays significantly enhance prognosis for large B-cell lymphoma, outperforming traditional PET assessments.

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

How do tertiary lymphoid structures influence immunotherapy outcomes in Merkel cell carcinoma? Spatial proteomics reveals key ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

Radiation therapy has been a foundation of cancer care for more than a century. From early X-ray machines to today’s ...

Explore innovative treatments for relapsed follicular lymphoma, focusing on novel therapies that enhance patient outcomes and ...

Lunsumio Velo is supplied as a ready-to-use, preservative-free solution in single-dose vials containing 5mg/0.5mL and 45mg/mL.

Standard Western medicine is reactive medicine. It primarily focuses on diagnosing and treating symptoms and diseases using ...